Actor
Argenx Switzerland SA
First-in-class therapies for rare diseases for the treatment of myasthenia gravis, for the treatment of severe IgM driven autoimmune diseases and other severe autoimmune diseases
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
Business model
1. Entreprise
1.5 Multinational
Organization Type
Private Company
Visit website
Domains
Dermatology, Endocrine & Metabolic, Immunology & Allergy, Neurology
Main sector
Biotech
Contact
Rue du Pré-de-la-Bichette 1
1202 Geneva / GE